Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple vitamin-dependent metabolic enzymes are a diverse class of proteins that require specific vitamins or their active metabolites as essential cofactors to perform their catalytic roles in human physiology (StatPearls, 2023). This group includes critical enzymes such as the biotin-dependent carboxylases involved in fatty acid synthesis and gluconeogenesis, thiamine-dependent dehydrogenases in the citric acid cycle, and vitamin K-dependent proteins essential for blood coagulation (NIH, 2023; PubChem). These enzymes are central to maintaining systemic metabolic homeostasis, and their dysfunction—whether due to nutritional deficiency, drug interference, or genetic mutations—can lead to a wide array of pathologies, including metabolic acidosis, neurological impairment, and coagulopathies (NORD, 2022). Pharmacologically, these enzymes are primarily addressed through cofactor replacement therapy (vitamin supplementation) to treat deficiencies or genetic disorders like multiple carboxylase deficiency (PubMed). Additionally, certain members of this group are therapeutic targets for inhibition, most notably the vitamin K-dependent coagulation factors which are modulated by oral anticoagulants like warfarin to manage thromboembolic risks (DrugBank).
These enzymes function by binding vitamin-derived cofactors (such as TPP, FAD, NAD, PLP, Biotin, or Cobalamin) which act as essential prosthetic groups or co-substrates for catalysis. Drugs targeting this group either provide the necessary exogenous cofactor to restore enzyme activity in deficiency states or competitively inhibit cofactor utilization or recycling (e.g., vitamin K epoxide reductase inhibition) to modulate enzyme function.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple vitamin-dependent metabolic enzymes.